In addition, GFAP expression (a marker of astrogliosis [28]) was increased in AD patients (Fig. 1G) and positively correlated with RTP801 levels (Fig. 1H), reinforcing the idea of RTP801 levels as a marker of neuropathological severity. This evidence concerns the gene DDIT4 and Alzheimer disease.